Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Milgrom

Concepts (370)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
41
2026
171
11.890
 Why?
Radiotherapy, Intensity-Modulated
17
2026
142
4.090
 Why?
Positron Emission Tomography Computed Tomography
17
2026
117
3.790
 Why?
Fluorodeoxyglucose F18
8
2026
161
2.310
 Why?
Tumor Burden
7
2026
324
2.300
 Why?
Radiotherapy
14
2025
204
2.190
 Why?
Antineoplastic Combined Chemotherapy Protocols
34
2026
1958
2.160
 Why?
Lymphoma
10
2025
233
2.070
 Why?
Radiotherapy Planning, Computer-Assisted
15
2026
149
2.050
 Why?
Whole-Body Irradiation
3
2026
74
1.890
 Why?
Radiation Injuries
9
2025
149
1.880
 Why?
Radiotherapy Dosage
18
2026
288
1.700
 Why?
Central Nervous System Neoplasms
9
2021
177
1.690
 Why?
Radiopharmaceuticals
6
2023
205
1.590
 Why?
Hematologic Neoplasms
2
2026
168
1.540
 Why?
Lymphoma, Non-Hodgkin
6
2024
124
1.440
 Why?
Neoplasm Staging
31
2026
1467
1.400
 Why?
Lymphoma, Large B-Cell, Diffuse
8
2024
193
1.260
 Why?
Sarcoma
2
2023
204
1.180
 Why?
Neoplasm Recurrence, Local
13
2023
1146
1.170
 Why?
Salvage Therapy
11
2024
165
1.160
 Why?
Neoplasms
8
2026
2900
1.140
 Why?
Mediastinal Neoplasms
5
2021
53
1.080
 Why?
Endometrial Neoplasms
4
2014
205
1.080
 Why?
Prognosis
24
2026
4310
1.050
 Why?
Combined Modality Therapy
22
2024
1264
1.030
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
698
1.020
 Why?
Radiotherapy, Adjuvant
7
2024
221
0.970
 Why?
Humans
124
2026
145140
0.960
 Why?
Lymphoma, Extranodal NK-T-Cell
1
2026
11
0.940
 Why?
Positron-Emission Tomography
9
2025
343
0.930
 Why?
Neoplasms, Radiation-Induced
2
2026
100
0.930
 Why?
Rhabdomyosarcoma
2
2024
64
0.920
 Why?
Neoplasms, Second Primary
2
2026
102
0.900
 Why?
Sarcoma, Ewing
2
2024
103
0.890
 Why?
Proton Therapy
2
2026
15
0.870
 Why?
Disease Progression
7
2024
2857
0.840
 Why?
Doxorubicin
14
2026
396
0.820
 Why?
Child
29
2026
22670
0.800
 Why?
Clinical Trials as Topic
2
2026
1058
0.800
 Why?
Radiation
2
2020
24
0.790
 Why?
Craniopharyngioma
1
2024
77
0.780
 Why?
Young Adult
36
2026
14176
0.780
 Why?
Radiation Exposure
1
2023
63
0.760
 Why?
Pituitary Neoplasms
1
2024
190
0.740
 Why?
Adenocarcinoma
3
2014
920
0.730
 Why?
Lymphoma, Follicular
5
2020
56
0.720
 Why?
Adolescent
34
2026
22479
0.720
 Why?
Salivary Glands
2
2021
36
0.710
 Why?
Smiling
1
2021
6
0.710
 Why?
Xerostomia
1
2021
13
0.690
 Why?
Retrospective Studies
39
2026
17247
0.680
 Why?
Tooth Abnormalities
1
2021
16
0.670
 Why?
Brachytherapy
1
2021
132
0.640
 Why?
Chemoradiotherapy
9
2021
239
0.630
 Why?
Face
1
2021
174
0.630
 Why?
Cancer Survivors
2
2026
337
0.620
 Why?
Bleomycin
9
2025
255
0.620
 Why?
Aged, 80 and over
23
2026
8318
0.610
 Why?
Vinblastine
9
2025
75
0.600
 Why?
Intraocular Lymphoma
2
2016
3
0.600
 Why?
Dacarbazine
9
2025
100
0.590
 Why?
Aged
43
2026
26096
0.590
 Why?
Adult
54
2026
40665
0.580
 Why?
Infertility, Female
2
2025
121
0.580
 Why?
Middle Aged
51
2026
36126
0.570
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
19
0.570
 Why?
Organs at Risk
4
2026
37
0.560
 Why?
Rectal Neoplasms
3
2016
159
0.560
 Why?
Female
64
2026
78636
0.550
 Why?
Cerebellar Neoplasms
1
2020
177
0.530
 Why?
Radiotherapy, Image-Guided
4
2026
39
0.530
 Why?
Breast Neoplasms
6
2026
2380
0.530
 Why?
Medulloblastoma
1
2020
215
0.530
 Why?
Recurrence
9
2020
1134
0.500
 Why?
Male
56
2026
72664
0.490
 Why?
Meningeal Neoplasms
1
2018
95
0.490
 Why?
Leukemia, Biphenotypic, Acute
1
2016
4
0.490
 Why?
Leukemia, Myeloid, Acute
2
2023
686
0.480
 Why?
Patient Satisfaction
1
2020
708
0.470
 Why?
Head and Neck Neoplasms
1
2021
561
0.470
 Why?
Treatment Outcome
26
2026
11741
0.450
 Why?
Mediastinum
4
2026
23
0.440
 Why?
Graft vs Host Disease
2
2024
278
0.440
 Why?
Eye Diseases
1
2016
97
0.440
 Why?
Brain Neoplasms
3
2023
1328
0.430
 Why?
Lower Urinary Tract Symptoms
2
2026
61
0.430
 Why?
Follow-Up Studies
16
2025
5411
0.420
 Why?
Survival Rate
12
2021
2087
0.420
 Why?
Disease-Free Survival
12
2020
766
0.400
 Why?
Glycolysis
3
2023
340
0.400
 Why?
Endometrium
1
2013
63
0.390
 Why?
Peritoneal Cavity
1
2013
30
0.390
 Why?
Palate, Hard
1
2012
5
0.380
 Why?
Digestive System Surgical Procedures
1
2014
112
0.380
 Why?
Lymphoma, B-Cell
3
2021
137
0.380
 Why?
Chemoradiotherapy, Adjuvant
3
2019
44
0.370
 Why?
Stomach Neoplasms
3
2019
128
0.370
 Why?
Mastectomy, Simple
1
2012
1
0.370
 Why?
Image Enhancement
1
2013
200
0.360
 Why?
Vincristine
5
2026
140
0.350
 Why?
Neoadjuvant Therapy
2
2016
465
0.350
 Why?
Child, Preschool
9
2026
11835
0.350
 Why?
Sentinel Lymph Node Biopsy
1
2012
117
0.340
 Why?
Carcinoma, Lobular
1
2012
56
0.340
 Why?
Carcinoma, Ductal, Breast
1
2012
89
0.340
 Why?
Adrenal Gland Neoplasms
1
2012
98
0.330
 Why?
Cyclophosphamide
4
2026
266
0.320
 Why?
Radiotherapy, Conformal
2
2026
74
0.320
 Why?
Rituximab
4
2026
210
0.310
 Why?
Biopsy
6
2020
1079
0.310
 Why?
Disease Management
6
2019
651
0.310
 Why?
Cellulitis
1
2009
54
0.300
 Why?
Tomography, X-Ray Computed
7
2023
2767
0.290
 Why?
Antineoplastic Agents
6
2025
2207
0.290
 Why?
Carcinoma, Squamous Cell
1
2014
640
0.280
 Why?
Prednisone
3
2026
221
0.280
 Why?
Kaplan-Meier Estimate
7
2020
968
0.280
 Why?
United States
6
2026
16065
0.280
 Why?
Lymphocytes
3
2020
376
0.280
 Why?
Lymphoma, Mantle-Cell
2
2019
35
0.270
 Why?
Organ Sparing Treatments
2
2026
37
0.260
 Why?
Coronary Artery Disease
2
2026
747
0.260
 Why?
Consensus
3
2024
478
0.250
 Why?
Survival Analysis
6
2020
1371
0.240
 Why?
Cardiotoxicity
2
2023
35
0.240
 Why?
Lung Neoplasms
3
2026
2662
0.240
 Why?
Pregnancy Complications, Neoplastic
2
2017
63
0.240
 Why?
Ifosfamide
1
2026
39
0.240
 Why?
Testicular Neoplasms
2
2018
111
0.240
 Why?
Credentialing
1
2026
21
0.230
 Why?
Radiation Pneumonitis
2
2016
31
0.230
 Why?
Multiple Myeloma
2
2020
309
0.230
 Why?
Patient Selection
2
2022
733
0.230
 Why?
Pelvic Neoplasms
1
2025
24
0.230
 Why?
Heart
3
2018
626
0.220
 Why?
Urinary Tract
1
2025
47
0.220
 Why?
Urodynamics
1
2025
44
0.220
 Why?
Lymph Node Excision
2
2019
173
0.220
 Why?
Antimetabolites, Antineoplastic
2
2017
105
0.220
 Why?
Risk Factors
6
2026
10857
0.210
 Why?
Leukemia
2
2017
246
0.210
 Why?
Risk Assessment
6
2023
3740
0.210
 Why?
Radiation Oncology
1
2025
82
0.210
 Why?
Transplantation, Haploidentical
1
2024
23
0.210
 Why?
Central Nervous System
3
2021
281
0.200
 Why?
Magnetic Resonance Imaging
4
2019
3892
0.200
 Why?
Uterus
1
2025
226
0.200
 Why?
Quality Assurance, Health Care
1
2025
342
0.200
 Why?
Lymphadenopathy
1
2023
8
0.200
 Why?
Virtual Reality
1
2025
82
0.190
 Why?
Lymphatic Metastasis
3
2014
331
0.190
 Why?
Cord Blood Stem Cell Transplantation
1
2024
103
0.190
 Why?
Transplantation Conditioning
1
2024
191
0.190
 Why?
Comprehension
1
2025
184
0.190
 Why?
Neoplasm Grading
4
2019
310
0.190
 Why?
Remission Induction
3
2018
306
0.190
 Why?
Protons
2
2020
96
0.180
 Why?
Brain Stem Neoplasms
1
2023
87
0.180
 Why?
Bone Neoplasms
1
2024
255
0.180
 Why?
Radiometry
2
2019
56
0.180
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
16
0.180
 Why?
Gastric Mucosa
2
2019
54
0.170
 Why?
Cohort Studies
6
2024
5988
0.170
 Why?
Chemotherapy, Adjuvant
2
2013
423
0.170
 Why?
Transplantation, Autologous
3
2018
298
0.170
 Why?
Survivors
2
2023
522
0.170
 Why?
Societies, Medical
1
2026
898
0.170
 Why?
Multimodal Imaging
3
2017
129
0.170
 Why?
Poly(ADP-ribose) Polymerases
1
2021
88
0.170
 Why?
Postoperative Complications
1
2014
2961
0.170
 Why?
Radium
1
2020
4
0.170
 Why?
Imaging, Three-Dimensional
1
2025
582
0.170
 Why?
Breath Holding
2
2017
10
0.160
 Why?
Long Term Adverse Effects
1
2020
13
0.160
 Why?
Artificial Intelligence
1
2025
381
0.160
 Why?
Cranial Irradiation
2
2023
85
0.160
 Why?
Patient Education as Topic
1
2025
775
0.150
 Why?
Skin Neoplasms
2
2018
848
0.150
 Why?
Stem Cell Transplantation
2
2018
189
0.150
 Why?
Plasmacytoma
1
2019
19
0.150
 Why?
Cardiology
1
2022
360
0.150
 Why?
Postoperative Care
2
2019
286
0.150
 Why?
CD4-CD8 Ratio
1
2018
23
0.150
 Why?
Radiation Dosage
1
2020
193
0.140
 Why?
Mycosis Fungoides
1
2018
62
0.140
 Why?
Prospective Studies
6
2026
8035
0.140
 Why?
Methotrexate
2
2017
233
0.140
 Why?
Electrons
1
2018
80
0.140
 Why?
Breast Neoplasms, Male
1
2018
29
0.140
 Why?
Area Under Curve
1
2019
329
0.140
 Why?
Glioma
1
2023
429
0.140
 Why?
Peritoneal Neoplasms
1
2019
104
0.130
 Why?
Radiotherapy Setup Errors
1
2017
3
0.130
 Why?
Platelet Count
1
2017
94
0.130
 Why?
Autografts
1
2018
55
0.130
 Why?
Hypothyroidism
1
2018
67
0.130
 Why?
Craniospinal Irradiation
1
2017
5
0.130
 Why?
Biomarkers
5
2026
4282
0.130
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
4
0.130
 Why?
Eye Neoplasms
1
2017
30
0.130
 Why?
Leukocyte Count
1
2017
316
0.130
 Why?
Osteogenesis Imperfecta
2
2007
14
0.120
 Why?
Uncertainty
1
2017
145
0.120
 Why?
Spinal Cord Diseases
1
2017
42
0.120
 Why?
Pentostatin
1
2016
4
0.120
 Why?
Neoplasm, Residual
1
2017
143
0.120
 Why?
Axilla
2
2017
51
0.120
 Why?
Photopheresis
1
2016
9
0.120
 Why?
Predictive Value of Tests
3
2022
2115
0.120
 Why?
Methylprednisolone
1
2016
59
0.120
 Why?
Plasmablastic Lymphoma
1
2015
8
0.120
 Why?
Confidence Intervals
1
2016
330
0.120
 Why?
Collagen Type I
2
2007
143
0.120
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
122
0.120
 Why?
Caregivers
2
2025
1070
0.110
 Why?
Fatal Outcome
1
2016
305
0.110
 Why?
Abortion, Spontaneous
1
2016
118
0.110
 Why?
Antibiotics, Antineoplastic
1
2016
139
0.110
 Why?
Congenital Abnormalities
1
2016
109
0.110
 Why?
Hysterectomy
2
2013
138
0.110
 Why?
Anxiety
1
2023
1117
0.110
 Why?
Tacrolimus
1
2016
195
0.110
 Why?
Transplantation, Homologous
1
2016
417
0.110
 Why?
Proportional Hazards Models
4
2020
1325
0.110
 Why?
Drug Resistance, Neoplasm
2
2019
881
0.110
 Why?
Blood Platelets
1
2017
379
0.100
 Why?
Receptors, Progesterone
2
2014
243
0.100
 Why?
Risk
1
2016
916
0.100
 Why?
Etoposide
3
2018
167
0.100
 Why?
Age Factors
1
2021
3338
0.100
 Why?
Kidney Neoplasms
1
2018
412
0.100
 Why?
Carboplatin
1
2013
161
0.090
 Why?
Receptors, Estrogen
2
2014
401
0.090
 Why?
Spinal Cord
1
2015
382
0.090
 Why?
Anti-Inflammatory Agents
1
2016
477
0.090
 Why?
Fluorouracil
1
2013
230
0.090
 Why?
Lung
2
2016
4101
0.090
 Why?
Pelvis
1
2013
125
0.090
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
1188
0.090
 Why?
Paclitaxel
1
2013
256
0.090
 Why?
Immunohistochemistry
1
2016
1713
0.090
 Why?
Neutrophils
1
2017
1123
0.090
 Why?
Immunoenzyme Techniques
1
2012
200
0.090
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1415
0.090
 Why?
Immunosuppressive Agents
1
2016
837
0.090
 Why?
Cisplatin
1
2013
344
0.080
 Why?
Triple Negative Breast Neoplasms
1
2014
218
0.080
 Why?
Brain
2
2020
2934
0.080
 Why?
Models, Biological
1
2018
1763
0.080
 Why?
Immunotherapy
1
2015
665
0.080
 Why?
Contrast Media
1
2013
497
0.080
 Why?
Polymorphism, Single Nucleotide
1
2016
2136
0.070
 Why?
Patient Compliance
1
2013
587
0.070
 Why?
Dose-Response Relationship, Radiation
2
2020
140
0.070
 Why?
Liver Neoplasms
1
2014
775
0.070
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
95
0.070
 Why?
Cytarabine
2
2018
66
0.060
 Why?
Biomarkers, Tumor
1
2014
1320
0.060
 Why?
Nerve Growth Factor
1
2026
35
0.060
 Why?
Integrins
1
2007
90
0.060
 Why?
Proteoglycans
1
2007
112
0.060
 Why?
Practice Guidelines as Topic
1
2014
1579
0.060
 Why?
Colorectal Neoplasms
1
2014
864
0.060
 Why?
Time Factors
4
2018
7107
0.060
 Why?
Treatment Failure
2
2018
360
0.060
 Why?
Amino Acid Substitution
1
2006
302
0.060
 Why?
Brain-Derived Neurotrophic Factor
1
2026
153
0.060
 Why?
Glycine
1
2006
186
0.060
 Why?
Neoplasm Invasiveness
2
2017
506
0.050
 Why?
Fertility Preservation
1
2025
55
0.050
 Why?
Clinical Decision-Making
2
2019
362
0.050
 Why?
Creatinine
1
2026
513
0.050
 Why?
American Heart Association
1
2026
357
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
14
0.050
 Why?
Intelligence Tests
1
2023
55
0.050
 Why?
Adenosine Triphosphate
1
2026
499
0.050
 Why?
Standard of Care
1
2024
81
0.050
 Why?
X-Rays
1
2023
27
0.050
 Why?
Cell- and Tissue-Based Therapy
1
2024
78
0.050
 Why?
Regression Analysis
2
2016
998
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
38
0.050
 Why?
Analysis of Variance
2
2016
1300
0.050
 Why?
Pregnancy
3
2025
7182
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
12
0.050
 Why?
Phenotype
3
2021
3138
0.050
 Why?
Cytidine Deaminase
1
2023
59
0.050
 Why?
Terminology as Topic
1
2024
256
0.050
 Why?
Brain Stem
1
2023
98
0.050
 Why?
Ribose
1
2021
22
0.040
 Why?
Adenosine Diphosphate
1
2021
83
0.040
 Why?
Troponin T
1
2021
63
0.040
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
53
0.040
 Why?
Feedback
1
2021
180
0.040
 Why?
Radiosurgery
1
2024
399
0.040
 Why?
Immunotherapy, Adoptive
1
2024
342
0.040
 Why?
Automation
1
2020
104
0.040
 Why?
Risk Management
1
2020
82
0.040
 Why?
Prevalence
2
2016
2855
0.040
 Why?
Incidence
2
2016
2915
0.040
 Why?
Mesentery
1
2019
44
0.040
 Why?
Infant
2
2025
10060
0.040
 Why?
Workflow
1
2020
183
0.040
 Why?
Neuropsychological Tests
1
2023
1134
0.040
 Why?
Busulfan
1
2018
15
0.030
 Why?
Respiration
1
2019
206
0.030
 Why?
Melphalan
1
2018
43
0.030
 Why?
Safety
1
2020
357
0.030
 Why?
Carmustine
1
2018
52
0.030
 Why?
Algorithms
1
2025
1845
0.030
 Why?
Inhalation
1
2017
29
0.030
 Why?
Cone-Beam Computed Tomography
1
2017
32
0.030
 Why?
Breast
1
2018
156
0.030
 Why?
Subacute Combined Degeneration
1
2017
1
0.030
 Why?
Phosphorylation
1
2021
1706
0.030
 Why?
Photons
1
2017
67
0.030
 Why?
Injections, Spinal
1
2017
119
0.030
 Why?
Deoxycytidine
1
2018
220
0.030
 Why?
Orbit
1
2017
66
0.030
 Why?
New York
1
2016
128
0.030
 Why?
Time-to-Treatment
1
2019
250
0.030
 Why?
Lymph Nodes
1
2019
502
0.030
 Why?
Homocysteine
1
2017
152
0.030
 Why?
Procarbazine
1
2015
9
0.030
 Why?
Genetic Markers
1
2016
333
0.030
 Why?
Observer Variation
1
2016
356
0.030
 Why?
Mutation
1
2007
4071
0.030
 Why?
Transforming Growth Factor beta1
1
2016
176
0.030
 Why?
Folic Acid
1
2017
198
0.030
 Why?
Texas
1
2016
272
0.030
 Why?
Animals
2
2021
37952
0.030
 Why?
Molecular Targeted Therapy
1
2018
438
0.030
 Why?
Mitochondria
1
2021
992
0.030
 Why?
Secondary Prevention
1
2016
251
0.030
 Why?
Gastrointestinal Diseases
1
2016
221
0.030
 Why?
Diagnostic Imaging
1
2017
337
0.030
 Why?
Abortion, Induced
1
2016
110
0.030
 Why?
Drug Administration Schedule
1
2016
781
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
296
0.030
 Why?
Pregnancy Outcome
1
2017
500
0.020
 Why?
Acute Disease
1
2016
1035
0.020
 Why?
Postpartum Period
1
2016
372
0.020
 Why?
Multivariate Analysis
1
2016
1546
0.020
 Why?
Diagnosis, Differential
1
2017
1506
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2018
917
0.020
 Why?
Mastectomy
1
2014
181
0.020
 Why?
Ultrasonography
1
2016
784
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2018
1138
0.020
 Why?
Surveys and Questionnaires
1
2025
6055
0.020
 Why?
Ovariectomy
1
2012
165
0.020
 Why?
Medical Oncology
1
2014
338
0.020
 Why?
Comorbidity
1
2016
1657
0.020
 Why?
Severity of Illness Index
1
2019
2928
0.020
 Why?
Diet
1
2017
1277
0.020
 Why?
Kidney
1
2017
1494
0.020
 Why?
Quality of Life
1
2021
3194
0.020
 Why?
Reproducibility of Results
1
2016
3410
0.020
 Why?
Electronic Health Records
1
2017
1188
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2351
0.020
 Why?
Anti-Bacterial Agents
1
2019
1922
0.020
 Why?
Electrophoresis
1
2006
31
0.020
 Why?
Case-Control Studies
1
2014
3616
0.010
 Why?
DNA Mutational Analysis
1
2007
407
0.010
 Why?
Databases, Genetic
1
2007
238
0.010
 Why?
Protein Structure, Tertiary
1
2007
855
0.010
 Why?
Collagen
1
2007
455
0.010
 Why?
Mice
1
2021
18303
0.010
 Why?
Binding Sites
1
2007
1309
0.010
 Why?
Protein Binding
1
2007
2235
0.010
 Why?
Cells, Cultured
1
2006
4142
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (370) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)